Publicacións nas que colabora con Luis Ángel León Mateos (10)

2015

  1. Side effects of targeted therapy

    Springer New York, pp. 377-416

  2. Treatment Of Sunitinib-Induced Hypertension In Solid Tumors By Nitric Oxid Donors

    Redox biology, Vol. 5, pp. 422

  3. Treatment of sunitinib-induced hypertension in solid tumor by nitric oxide donors

    Redox Biology, Vol. 6, pp. 421-425

2014

  1. Metastatic castration-resistant prostate cancer: Changing landscape with cabazitaxel

    Anti-Cancer Drugs, Vol. 25, Núm. 3, pp. 237-243

2013

  1. Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

    Clinical and Translational Oncology, Vol. 15, Núm. 6, pp. 425-433

  2. Erratum: Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor (Clinical and Translational Oncology DOI: 10.1007/s12094-012-0985-x)

    Clinical and Translational Oncology

2012

  1. Starvation profile of mTOR inhibitors

    Rapamycin: Effectiveness, Safety and Drug Interactions (Nova Science Publishers, Inc.), pp. 31-52

  2. Sunitinib: The first to arrive at first-line metastatic renal cell carcinoma

    Advances in Therapy, Vol. 29, Núm. 3, pp. 202-217

2011

  1. Expression of notch1 to -4 and their ligands in renal cell carcinoma: A tissue microarray study

    Cancer Genomics and Proteomics, Vol. 8, Núm. 2, pp. 93-101

  2. Molecular basis of hypertension side effects induced by sunitinib

    Anti-Cancer Drugs, Vol. 22, Núm. 1, pp. 1-8